Cancer
GSK hopeful of NICE approval for Tyverb
January 26, 2009Sales and Marketing Cancer, GSK, breast cancer
NICE could be poised to reverse its rejection of GSK's breast cancer treatment Tyverb, the pharma company has said.NICE rejected …
Working Life: Les Hughes
January 8, 2009Research and Development AstraZeneca, Cancer, clinical research, infection
How did you find your way into your role? I wanted to be a chemist from my very first experience …
Abraxis Biosciences launches Abraxane in Europe
January 2, 2009Sales and Marketing Abraxis, Cancer, EU
US biotech company Abraxis BioScience has launched its innovative breast cancer treatment Abraxane in Europe. The drug is a variant …
BMS breast cancer drug rejected
November 27, 2008Sales and Marketing BMS, Cancer, breast cancer
Bristol-Myers Squibb's breast cancer drug Ixempra has suffered a setback in the EU over safety concerns.The Committee for Medicinal Products …
Boehringer’s cancer drug enters phase III
November 21, 2008Sales and Marketing Boehringer, Cancer
Boehringer Ingelheim's new lung cancer drug Vargatef has entered phase III trials.The drug is part of the manufacturer's burgeoning oncology …
Lilly eyes oncology focus with ImClone acquisition
October 9, 2008Sales and Marketing Cancer, MA, lilly
Lilly is to buy ImClone for $6.5 billion after outbidding Bristol-Myers Squibb for the biotech company. Lilly says the acquisition …
Gardasil and Cervarix share innovation prize
September 25, 2008Sales and Marketing Cancer, Gardasil, prix galien, vaccines
Rival vaccine products that will prevent thousands of women developing cervical cancer have been declared joint winners of the prestigious …
Brown to scrap prescription costs for cancer patients
September 24, 2008Cancer, NHS
Patients suffering from cancer won't have to pay for prescriptions after April next year under new government plans. Prime minister …
GSK seeks risk-sharing deal for Tyverb
September 17, 2008Sales and Marketing Cancer, GSK, NICE, par
GlaxoSmithKline has approached the government for a new pricing deal on its breast cancer drug Tyverb, which could make it …
GSK unveils new cancer unit
September 17, 2008Research and Development Cancer, GSK
GSK has unveiled a new integrated oncology R&D unit aimed at enhancing its presence in cancer care.The unit will be …
Patient wins legal battle for Revlimid
September 12, 2008Sales and Marketing Cancer, Revlimid
A cancer patient has won access to cancer drug Revlimid in a court battle with his local PCT. West Sussex …
Government looks set to allow top-up fees
September 10, 2008Sales and Marketing Cancer, Karol Sikora, NICE
Patients in the UK could soon gain official clearance to pay ‘top up’ fees in order to receive the cancer …
European research centres unite to battle cancer
September 9, 2008Research and Development Cancer, EU, France, Netherlands, Sweden
Top oncology specialists across Holland, France and Sweden have formed a new alliance to improve cancer research and reduce treatment …
The Pharmafocus Interview: Martin Dawkins
September 4, 2008Research and Development, Sales and Marketing Bayer, Cancer, NICE, Xarelto, healthcare
Martin Dawkins is an Englishman born and bred, but has spent most of his career working abroad, including the US, …
A new kind of patient advocate
July 30, 2008Sales and Marketing Cancer, campaigner, market access, patient
When I came to interview Kate Spall, it was she, not I, who fired the first few questions. Her approach …
Latest content
AstraZeneca’s Trixeo approved in EU for asthma
ESTEVE CDMO adds $17.5m to Illinois expansion
